MedTrace Logo

Improvement in Baroreflex Sensitivity in OSAS

NCT00284037 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2006-01-31

No results posted yet for this study

Summary

Individuals with obstructive sleep apnea syndrome (OSAS) are at high risk for cardiovascular morbidity and mortality. The effect of long-term nocturnal therapy with continuous positive airway pressure (CPAP) on daytime baroreflex sensitivity (BRS), a predictor of cardiac death, was investigated in OSAS patients.

Conditions

  • Obstructive Sleep Apnea Syndrome

Interventions

DEVICE

continuous positive airway pressure therapy

Sponsors & Collaborators

  • Nagoya University

    lead OTHER

Principal Investigators

  • Mitsuhiro Yokota, MD.PhD · Department of Cardiovascular Genome Science, Nagoya University School of Medicine, Nagoya, Aichi, Japan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00284037 on ClinicalTrials.gov